Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Administrative updates: Revision: v3.4.2 was added, while Revision: v3.4.1 and a government funding/status notice were removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:25:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top with a link to opm.gov, and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T07:54:28.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI/metadata updates include showing the glossary, adding 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and removing or altering older labels ('Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4') as well as changes to 'No FEAR Act Data'.
    Difference
    0.2%
    Check dated 2026-01-28T04:44:39.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive study information or documents were changed.
    Difference
    0.1%
    Check dated 2026-01-14T02:38:56.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations sections were reorganized: a main Locations section added with state subheadings (California, Illinois, New York, North Carolina, Ohio) and the prior state-specific sections removed; the page revision notes show an update from v3.3.2 to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T17:29:42.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publication note now states that PubMed entries are automatically filled and may not pertain to the study, and the revision tag has been updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T20:57:29.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.